Lesions most often occur at sites of pressure (e.g., the heel), particularly in areas of poor sensory function and poor circulation (Fig. 34.4).
Diabetic neuropathic ulcers should be distinguished from infections and other ulcerations and cutaneous neoplasms that may present as ulcers.
Acanthosis nigricans (Fig. 34.5) sometimes occurs in insulin-resistant diabetes (also see Figs. 23.19 and 23.20).
Cutaneous candidiasis may also occur (see Figs. 18.17-18.22)
Eruptive xanthomas are seen as skin markers for various primary genetic disorders such as certain types of hyperlipidemias or secondary to diabetes (see discussion later in this chapter).
Diabetic dermopathy is characterized by small brownish, atrophic, scarred, hyperpigmented plaques (Fig. 34.6).
Perforating folliculitis (Kyrle disease) consists of firm, rough, hyperkeratotic papules, which are often hyperpigmented in dark-skinned people.
Disseminated granuloma annulare consists of annular dermal papules (see Chapter 15: InflAMmatory Eruptions of Unknown Cause) that occur both in patients with clinical diabetes and sometimes in individuals with only abnormal glucose levels.
Scleredema of Buschke-Löwenstein is a rare manifestation of diabetes mellitus. The lesion is a sclerotic, thickened plaque characteristically seen on the upper back.
Serum glucose levels and glycosylated hemoglobin A1C are determined to confirm the diagnosis of diabetes mellitus.
Skin biopsies of lesions of necrobiosis lipoidica and granuloma annulare demonstrate palisading granulomas with degeneration of collagen.
Skin biopsy of perforating folliculitis demonstrates basophilic material in the dermis, with transepidermal elimination.
Skin biopsies of diabetic dermopathy show thickening of blood vessels and mild perivascular infiltrate.
Diabetic bullous lesions have subepidermal blistering on hematoxylin and eosin staining of skin biopsy tissue; direct immunofluorescence of skin biopsies in these lesions is negative for immunoglobulins.